Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡